BlackRock Capital Allocation Term Trust (NYSE:BCAT) Hits New 1-Year Low – Should You Sell?

Posted by Tammy Falkenburg on Mar 29th, 2025

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $14.46 and last traded at $14.51, with a volume of 310923 shares changing hands. The stock had previously closed at $14.58.

BlackRock Capital Allocation Term Trust Stock Performance

The business’s fifty day moving average price is $15.28 and its 200-day moving average price is $15.79.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently disclosed a monthly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be given a dividend of $0.2872 per share. This represents a $3.45 dividend on an annualized basis and a yield of 24.04%. The ex-dividend date is Friday, March 14th. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

Hedge funds have recently modified their holdings of the business. CIBC Private Wealth Group LLC bought a new stake in BlackRock Capital Allocation Term Trust during the fourth quarter valued at about $36,000. Anfield Capital Management LLC purchased a new position in BlackRock Capital Allocation Term Trust in the fourth quarter worth about $56,000. MassMutual Private Wealth & Trust FSB purchased a new position in shares of BlackRock Capital Allocation Term Trust in the 4th quarter worth approximately $112,000. Comerica Bank boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 27.1% in the 4th quarter. Comerica Bank now owns 10,126 shares of the company’s stock worth $153,000 after purchasing an additional 2,157 shares during the period. Finally, Cutter & CO Brokerage Inc. bought a new position in shares of BlackRock Capital Allocation Term Trust during the 4th quarter valued at approximately $158,000. Institutional investors own 36.12% of the company’s stock.